Sagittarius Life Science Corp

TPEX:3205 Stock Report

Market Cap: NT$1.1b

Sagittarius Life Science Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sagittarius Life Science.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Personal Products earnings growth18.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

We Think Sagittarius Life Science (GTSM:3205) Can Afford To Drive Business Growth

Apr 11
We Think Sagittarius Life Science (GTSM:3205) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Sagittarius Life Science's (GTSM:3205) Cash Burn Situation

Dec 27
Here's Why We're Not Too Worried About Sagittarius Life Science's (GTSM:3205) Cash Burn Situation

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sagittarius Life Science has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:3205 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024447-55-36-35N/A
3/31/2024443-50-32-30N/A
12/31/2023440-55-71-69N/A
9/30/2023459-55-21-19N/A
6/30/2023489-55-49-46N/A
3/31/2023509-67-67-65N/A
12/31/2022529-74-54-53N/A
9/30/2022545-78-49-48N/A
6/30/2022555-91-48-47N/A
3/31/2022574-86-52-49N/A
12/31/2021588-86-38-29N/A
9/30/2021592-83-75-67N/A
6/30/2021575-81-75-67N/A
3/31/2021557-86-57-50N/A
12/31/2020558-74-73-62N/A
9/30/2020521-99-119-103N/A
6/30/2020506-106-119-125N/A
3/31/2020492-103-128-133N/A
12/31/2019439-120-119-105N/A
9/30/2019429-113-86-76N/A
6/30/2019410-107-54-23N/A
3/31/2019399-84-291N/A
12/31/2018411-92-58-58N/A
9/30/2018412-107-35-35N/A
6/30/2018430-115-37-37N/A
3/31/2018435-129N/A-111N/A
12/31/2017463-114N/A-23N/A
9/30/2017528-41N/A7N/A
6/30/2017622-7N/A152N/A
3/31/2017960106N/A518N/A
12/31/20161,384268N/A360N/A
9/30/20161,716393N/A370N/A
6/30/20161,862493N/A468N/A
3/31/20161,643422N/A154N/A
12/31/20151,240301N/A238N/A
9/30/2015895171N/A266N/A
6/30/201566569N/A-7N/A
3/31/201553641N/A-4N/A
12/31/201443910N/A60N/A
9/30/201436811N/A26N/A
6/30/201435216N/A13N/A
3/31/20143103N/A7N/A
12/31/20132951N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 3205's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if 3205's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 3205's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 3205's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 3205's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 3205's Return on Equity is forecast to be high in 3 years time


Discover growth companies